Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2012
08/09/2012US20120201829 Human Monoclonal Antibody Against S. Aureus Derived Alpha-Toxin and Its Use in Treating or Preventing Abscess Formation
08/09/2012US20120201828 Antibodies that specifically bind to the epha2 receptor
08/09/2012US20120201827 Anti-cd38 antibodies
08/09/2012US20120201826 Anti-RANTES Antibodies and Methods of Use Thereof
08/09/2012US20120201825 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
08/09/2012US20120201824 Compositions and Methods for Inhibiting an Oncogenic Protein to Enhance Immunogenicity
08/09/2012US20120201823 April antagonists and methods of use
08/09/2012US20120201822 Tumor treatment
08/09/2012US20120201821 Treatment of Gastrointestinal Inflammation and Psoriasis and Asthma
08/09/2012US20120201820 Immunological compositions as cancer therapeutics
08/09/2012US20120201819 Treatment of drug-related side effect and tissue damage by targeting the cd-24-hmgb1-siglec10 axis
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012US20120201817 Methods of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist
08/09/2012US20120201816 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
08/09/2012US20120201815 Methods of altering bone growth by administration of sost or wise antagonist or agonist
08/09/2012US20120201814 Compositions monovalent for cd28 binding and methods of use
08/09/2012US20120201813 Polypeptide variants with altered effector function
08/09/2012US20120201812 Stable formulations of polypeptides and uses thereof
08/09/2012US20120201811 Generation and use of fab, scfv, and related binding molecules specific for hiv-1 rev
08/09/2012US20120201810 Use of Anti-DKK-1 Monoclonal Antibodies for the Treatment of Liver Cancer
08/09/2012US20120201809 Multifunctional antibody conjugates
08/09/2012US20120201808 Stem Cell Fusion Model of Carcinogenesis
08/09/2012US20120201807 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
08/09/2012US20120201806 Liquid-retaining elastomeric compositions
08/09/2012US20120201782 Peptide, adjuvants, vaccines, and methods of use
08/09/2012US20120201781 Treatment of osteoarthritis and pain
08/09/2012US20120201756 Plasma kallikrein binding proteins
08/09/2012US20120201752 Foxc1 antibodies and methods of their use
08/09/2012US20120201751 Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44
08/09/2012US20120201750 Serum biomarkers for melanoma metastasis
08/09/2012US20120199516 Method for treating multiple sclerosis
08/09/2012CA2826594A1 Multivalent vaccines for rabies virus and filoviruses
08/09/2012CA2826453A1 Use of an anti-cd200 antibody for prolonging the survival of allografts
08/09/2012CA2826420A1 Expandable liquid volume in an led bulb
08/09/2012CA2826286A1 Treatment of tauopathies
08/09/2012CA2826144A1 Foxc1 antibodies and methods of their use
08/09/2012CA2826060A1 Immunogenic bordetella bronchiseptica compositions
08/09/2012CA2826058A1 Compositions for canine respiratory disease complex
08/09/2012CA2825990A1 Anti-tace antibody molecules and their uses
08/09/2012CA2825969A1 Dosing for treatment with anti-egfl7 antibodies
08/09/2012CA2825884A1 Ubiquitin interacting motif peptides as cancer therapeutics
08/09/2012CA2824089A1 Selection and treatment of subjects
08/08/2012EP2484757A1 Virus capable of expressing -galactose epitope, and method for production of vaccine
08/08/2012EP2484752A2 Extracellular vesicles derived from gram-positive bacteria, and use thereof
08/08/2012EP2484697A1 Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody
08/08/2012EP2484696A1 Antagonistic human light-specific human monoclonal antibodies
08/08/2012EP2484693A1 Human serum amyloid-a3 antibody and use thereof
08/08/2012EP2484381A1 Composition for a treatment of demyelinating diseases and paralysis by administration of remyelinating agents
08/08/2012EP2484380A1 Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effect
08/08/2012EP2484379A1 Agent for prevention of atherosclerosis
08/08/2012EP2484378A1 Hepatitis c virus vaccine composition
08/08/2012EP2484377A1 Low-additive influenza vaccines
08/08/2012EP2484376A1 Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of dna and chimeric virus vaccines
08/08/2012EP2484375A2 Vaccine composition containing synthetic adjuvant
08/08/2012EP2484374A1 Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses
08/08/2012EP2484343A1 Hepatitis b virus antigen formulation for cell stimulation followed by therapeutic immunization
08/08/2012EP2483396A2 Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7
08/08/2012EP2483389A2 Hyperblebbing shigella strains
08/08/2012EP2483316A1 Anti-fibroblast activation protein antibodies and methods and uses thereof
08/08/2012EP2483312A1 Antibodies that specifically bind to the epha2 receptor
08/08/2012EP2483308A1 Drug fusions and conjugates with extended half life
08/08/2012EP2483307A1 Influenza hemagglutinin antibodies, compositions, and related methods
08/08/2012EP2483303A1 T-cell receptor capable of recognising an antigen from cytomegalovirus
08/08/2012EP2482849A2 Combination immunotherapy for the treatment of cancer
08/08/2012EP2482848A1 Endoglin antibodies
08/08/2012EP2482847A1 Purification of bacterial vesicles
08/08/2012EP2482846A1 Infectious hepatitis c viruses of genotype 3a and 4a and uses thereof
08/08/2012EP2482845A2 Novel vaccine composition against influenza
08/08/2012EP2482844A1 Adjuvanted vaccine formulations
08/08/2012EP2482843A1 Methods of improving vaccine immunogenicity
08/08/2012EP2482834A1 Peptides for inducing heterosubtypic influenza t cell responses
08/08/2012EP2482825A1 Piscine reovirus diagnostic compositions
08/08/2012EP2482824A1 Piscine reovirus immunogenic compositions
08/08/2012EP2482804A1 Microparticle compositions and methods for treating age-related macular degeneration
08/08/2012EP2152753B1 Antibodies against ramp3
08/08/2012EP2118318B1 Gnaq mutations in melanoma
08/08/2012EP2090318B1 Prophylactic tuberculosis vaccine
08/08/2012EP1690550B1 Therapeutic agent for mesothelioma
08/08/2012EP1585760B1 Btl-ii nucleic acids, proteins, and antibodies
08/08/2012EP1569685B1 Complement receptor 2 targeted complement modulators
08/08/2012EP1127148B1 Variants of humanized anti-carcinoma monoclonal antibody cc49
08/08/2012EP0951551B2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
08/08/2012CN1930288B Cells of which genome is modified
08/08/2012CN1901936B Cytotoxicity mediation of cells evidencing surface expression of cd44
08/08/2012CN1576281B Viral clearance process
08/08/2012CN102630229A Treating notch1-antagonist-resistant cancer (s) using notch3 antagonists
08/08/2012CN102630168A Methods for treating psoriasis
08/08/2012CN102630167A Treatment of neurological conditions
08/08/2012CN102630166A Vaccine against cholera and enterotoxigenic e. coli (ETEC) diarrhea
08/08/2012CN102630165A Novel dosing regimen and method of treatment
08/08/2012CN102630163A Bacterial spore having therapeutic agent adsorbed on its surface
08/08/2012CN102628074A Proteolysis resistant antibody preparations
08/08/2012CN102628054A Enterovirus 71 capsid protein 3 recombinant antigen and application thereof
08/08/2012CN102628053A Construction and application of recombinant Chicken Marek's Disease Virus SC9-1 strain and SC9-2 strain
08/08/2012CN102626520A Heat-resisting cryoprotectant of mink canine distemper live vaccine and preparation method thereof
08/08/2012CN102626516A Pseudomonas aeruginosa and propolis inactivated vaccine for minks and preparation process
08/08/2012CN102626515A Process for activating Haemophilus influenzae type b (Hib) polysaccharide conjugate vaccine
08/08/2012CN102626514A Soft-shelled turtle systemic septicemia spherical virus inactivated vaccine and its preparation method
08/08/2012CN102626513A Mink streptococcus propolis inactivated vaccine and preparation technology thereof
08/08/2012CN102626422A Human sperm specific transfer factor oral preparation and preparation process thereof
1 ... 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 ... 1823